Actively Recruiting
An International Study on Pediatric Patients With Rare Tumors.
Led by Azienda Ospedaliera di Padova · Updated on 2025-07-18
6250
Participants Needed
1
Research Sites
1271 weeks
Total Duration
On this page
Sponsors
A
Azienda Ospedaliera di Padova
Lead Sponsor
S
St. Anna Children's Hospital, Vienna
Collaborating Sponsor
AI-Summary
What this Trial Is About
The PARTNER study is an international, prospective, observational study of paediatric patients with very rare tumours.
CONDITIONS
Official Title
An International Study on Pediatric Patients With Rare Tumors.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children and adolescents (age 0-18 years) with a primary or relapsed Very Rare Tumor diagnosed and/or treated in a participating country/center
- Written informed consent from the patient and/or the parent/legal guardian
You will not qualify if you...
- Absence of Written informed consent from the patient and/or the parent/legal guardian
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Pediatric Oncology Unit, University Hospital Padova [AOUP Azienda Ospedale Università Padova]
Padova, Italy, Italy, 35127
Actively Recruiting
Research Team
G
Gianni Bisogno, MD
CONTACT
M
Martina Bonel, CRC
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here